skip to main content
Idioma:

Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials

Sarris, Jerome ; Mischoulon, David ; Schweitzer, Isaac

Bipolar disorders, 2011-08, Vol.13 (5-6), p.454-465 [Revista revisada por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponible

Citas Citado por
  • Título:
    Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials
  • Autor: Sarris, Jerome ; Mischoulon, David ; Schweitzer, Isaac
  • Materias: adjunctive ; Amino Acids - therapeutic use ; Antimanic Agents - therapeutic use ; bipolar depression ; bipolar disorder ; Bipolar Disorder - diet therapy ; Bipolar Disorder - drug therapy ; Clinical Trials as Topic - methods ; Clinical Trials as Topic - standards ; Databases, Factual - statistics & numerical data ; depression ; Dietary Supplements ; Fatty Acids, Omega-3 - therapeutic use ; Humans ; mania ; Minerals - therapeutic use ; mood stabilizers ; nutraceuticals ; nutrients ; omega-3 ; Treatment Outcome ; Vitamins - therapeutic use
  • Es parte de: Bipolar disorders, 2011-08, Vol.13 (5-6), p.454-465
  • Notas: ark:/67375/WNG-0XG08P9Z-7
    ArticleID:BDI945
    istex:B833EEE27D13A500EAE099FAEA86C9A5E4533AA1
    Disclosure information for all authors is listed before the references.
    SourceType-Scholarly Journals-1
    ObjectType-Feature-4
    ObjectType-Undefined-1
    content type line 23
    ObjectType-Review-2
    ObjectType-Article-3
  • Descripción: Sarris J, Mischoulon D, Schweitzer I. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials.
Bipolar Disord 2011: 13: 454–465. © 2011 The Authors. Journal compilation © 2011 John Wiley & Sons A/S. Objective:  Studies using augmentation of pharmacotherapies with nutraceuticals in bipolar disorder (BD) have been conducted and preliminary evidence in many cases appears positive. To date, however, no specialized systematic review of this area has been conducted. We present the first systematic review of clinical trials using nutrient‐based nutraceuticals in combination with standard pharmacotherapies to treat BD. A subsequent aim of this report was to discuss posited underlying mechanisms of action. Methods:  PubMed, CINAHL, Web of Science, and Cochrane Library databases, and grey literature were searched during mid‐2010 for human clinical trials in English using nutraceuticals such as omega‐3, N‐acetyl cysteine (NAC), inositol, and vitamins and minerals, in combination with pharmacotherapies to treat bipolar mania and bipolar depression. A review of the results including an effect size analysis (Cohen’s d) was subsequently conducted. Results:  In treating bipolar depression, positive evidence with large effect sizes were found for NAC (d = 1.04) and a chelated mineral and vitamin formula (d = 1.70). On the outcome of bipolar mania, several nutraceuticals reduced mania with strong clinical effects: a chelated mineral formula (d = 0.83), L‐tryptophan (d = 1.47), magnesium (d = 1.44), folic acid (d = 0.40), and branched‐chain amino acids (d = 1.60). Mixed, but mainly positive, evidence was found for omega‐3 for bipolar depression, while no evidentiary support was found for use in mania. No significant effect on BD outcome scales was found for inositol (possibly due to small samples). Conclusions:  BD treatment outcomes may potentially be improved by additional use of certain nutraceuticals with conventional pharmacotherapies. However, caution should be extended in interpreting the large effects of several isolated studies, as they have not yet been replicated in larger trials.
  • Editor: Oxford, UK: Blackwell Publishing Ltd
  • Idioma: Inglés
Enlaces
Volver a la lista de resultados
Ir a la página anteriorAnterior Resultado  3 SiguienteIr a la siguiente página

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora